In the parent program project we had hypothesized that AC5 disruption (knock out, KO) was a model of longevity and planned to compare it to the most widely studied model of longevity, caloric restriction (CR). We hypothesized that the combination of AC5 KO and CR might result in even greater longevity, if there were sufficiently different mechanisms involved that could act synergistically. In the first two years of the program project the testing of this hypothesis resulted in dramatically different results, i.e., the AC5 KO mice with superimposed CR all died within one month. The goal of this revised application is to investigate the mechanisms in depth mediating this lethal combination, since the shared molecular and cellular mechanisms are likely the key molecular mechanisms mediating longevity and stress resistance. Since both models demonstrate significant alterations in metabolism, first we will examine the major mechanisms involved in response to limited caloric intake or to enhanced metabolism, e.g., glucose utilization, depletion of glycogen stores, and utilization of fatty acids. Next we will examine the molecular mechanisms shared by these major models of longevity and stress resistance by genomic and proteomic investigation. To accomplish this we are proposing a fourth Project for this Program Project. The new project ('Common Longevity Mechanisms in Caloric Restriction and AC5 Knockout') will also utilize all the Cores (Core A: Administration/ Physiology, Core B: Animal Care, Core C: Proteomics/Genomics, Core D: Bioinformatics/Biostatistics and Core E: Pathology). The central hypothesis of this revised revision application is that AC5 inhibition and CR induce longevity and stress resistance through similar mechanisms, and that this project will identify the shared mechanisms, which are both common and unique, mediating longevity and stress resistance.
Specific Aim 1 : To examine glucose and fatty acid metabolism in blood, liver, heart, skeletal muscle and adipose tissue in AC5 KO mice and compare to WT with moderate and severe caloric restriction. A second goal will be to compare the effects of superimposition of the two levels of CR in AC5 KO.
Specific Aim 2 : To determine the cause of death in AC5 KO mice with superimposition of CR using pathology, histology and biochemistry.
Specific Aim 3 : To determine shared molecular mechanisms that regulate longevity, stress resistance and metabolism in AC5 KO and CR using genomic and proteomic approaches.

Public Health Relevance

Adenylyl cyclase type S (AC5) disruption (knock out, KO) and caloric restriction (CR), two models of longevity, are lethal when combined. This project will identify the shared mechanisms, which are both common and unique in these two models, and that mediate longevity and stress resistance. These are both major public health issues, particularly in view of the increasing age of the US population.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
3P01AG027211-06S1
Application #
8682004
Study Section
Special Emphasis Panel (ZAG1 (O2))
Program Officer
Kohanski, Ronald A
Project Start
2013-09-12
Project End
2015-09-11
Budget Start
2013-09-12
Budget End
2015-09-11
Support Year
6
Fiscal Year
2013
Total Cost
$69,793
Indirect Cost
$25,898
Name
Rutgers University
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
078795851
City
Newark
State
NJ
Country
United States
Zip Code
07103
Vatner, Dorothy E; Zhang, Jie; Oydanich, Marko et al. (2018) Enhanced longevity and metabolism by brown adipose tissue with disruption of the regulator of G protein signaling 14. Aging Cell :e12751
Guers, John J; Zhang, Jie; Campbell, Sara C et al. (2017) Disruption of adenylyl cyclase type 5 mimics exercise training. Basic Res Cardiol 112:59
Vatner, Stephen F (2016) Why So Few New Cardiovascular Drugs Translate to the Clinics. Circ Res 119:714-7
Bravo, Claudio A; Vatner, Dorothy E; Pachon, Ronald et al. (2016) A Food and Drug Administration-Approved Antiviral Agent that Inhibits Adenylyl Cyclase Type 5 Protects the Ischemic Heart Even When Administered after Reperfusion. J Pharmacol Exp Ther 357:331-6
Pachon, Ronald E; Scharf, Bruce A; Vatner, Dorothy E et al. (2015) Best anesthetics for assessing left ventricular systolic function by echocardiography in mice. Am J Physiol Heart Circ Physiol 308:H1525-9
Vatner, Dorothy E; Yan, Lin; Lai, Lo et al. (2015) Type 5 adenylyl cyclase disruption leads to enhanced exercise performance. Aging Cell 14:1075-84
Sehgel, Nancy L; Sun, Zhe; Hong, Zhongkui et al. (2015) Augmented vascular smooth muscle cell stiffness and adhesion when hypertension is superimposed on aging. Hypertension 65:370-7
Sciarretta, Sebastiano; Yee, Derek; Ammann, Paul et al. (2015) Role of NADPH oxidase in the regulation of autophagy in cardiomyocytes. Clin Sci (Lond) 128:387-403
Yuan, Chujun; Yan, Lin; Solanki, Pallavi et al. (2015) Blockade of EMAP II protects cardiac function after chronic myocardial infarction by inducing angiogenesis. J Mol Cell Cardiol 79:224-31
Ho, David; Zhao, Xin; Yan, Lin et al. (2015) Adenylyl Cyclase Type 5 Deficiency Protects Against Diet-Induced Obesity and Insulin Resistance. Diabetes 64:2636-45

Showing the most recent 10 out of 113 publications